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Foreword: 
 
“While the individual man is an absolute puzzle, in the aggregate he 
becomes a mathematical certainty. You can, for example, never foretell 
what any one man will do, but you can say with precision what an average 
number will be up to. Individuals vary, but percentages remain constant.” 
 
Ref: Sherlock Holmes, in The Sign of Four 
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Abstract 
Patellofemoral pain syndrome (PFPS) is characterized by long-term diffuse peripatellar and 
retropatellar localized pain in one or both knees, which worsens during walking uphill or 
downhill, squatting, kneeling, or prolonged sitting with flexed knees. There is no consensus 
in the medical literature concerning the definition, aetiology or diagnosis of PFPS. In this 
thesis PFPS is described as anterior knee pain excluding intra-articular pathology, 
peripatellar tendonitis and bursitis. Clinical tests used to diagnose PFPS lack acceptable 
reliability and validity, and radiographic findings in diagnosing PFPS are inconclusive. These 
limitations need to be addressed given that PFPS is a common musculoskeletal complaint, 
especially among adolescents and young active adults. The main purpose of the studies 
described in this thesis was to determine possible pain mechanisms in PFPS patients and to 
suggest a suitable treatment modality.  
 
The first study reported in the thesis was a randomized clinical trial involving the treatment 
of 36 PFPS patients with sensory stimulation by 8 acupuncture treatments. The control 
group consisting of 34 PFPS subjects did not receive any treatment. The two groups did not 
differ at baseline. The Cincinnati Rating System questionnaire was used as the main outcome 
measure. The results show that the Numbers Necessary to Treat (NNT) was 3.2 to achieve no 
pain or occasional pain to strenuous sports at the 12-month follow-up, and 3.7 to achieve no 
functional limitations or some limitations to heavy labour, in favour of the acupuncture 
group. Hence, sensory stimulation by acupuncture is recommended as a treatment modality 
to improve pain and function in PFPS patients. 
 
The second study assessed the mental status of 25 PFPS patients and related this to pain and 
function. The health status was significantly lower and mental distress was significantly 
higher in PFPS patients than in a comparable group comprising 23 healthy subjects. Further, 
the level of mental distress increased and the health status deteriorated with increased 
intensity of pain and impairment of knee function. We hypothesize that pain and reduced 
function produce mental distress in PFPS patients, and that this influences their experience 
of pain. 
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The third study measured somatosensory functions related to the painful area using thermal 
and tactile quantitative sensory testing (QST) and bedside neurological tests in 25 PFPS 
patients. The results were compared to those obtained in 23 healthy controls. We found that 
QST can be used to detect sensory dysfunctions in patients with PFPS. Patients suffering 
from unilateral PFPS demonstrated dysfunction of sensory pathways related to the painful 
and contralateral areas, which might indicate a pathophysiological basis for pain in PFPS. 
 
The fourth study assessed if a subgroup of PFPS patients experienced neuropathic pain 
related to the painful knee by characterizing the somatosensory phenotype and analysing 
the sensory and clinical patterns related to the knees. A total of 91 subjects with unilateral 
PFPS and a comparable group of 23 healthy subjects were included in this study with a case–
control design. The degree of knee function and intensity of knee pain were assessed. 
Somatosensory assessments were carried out by bedside neurological tests and by assessing 
thermal, tactile and vibration thresholds. There was considerable heterogeneity and overlap 
in the degree and type of aberrations of the nervous system. However, no subgroup of 
subjects with neuropathic pain or clustering of features related to neuropathic pain was 
identified. 
 
Conclusions from this thesis: 
 Somatosensory stimulation by acupuncture is recommended as a treatment modality 
for PFPS. 
 Quantitative sensory testing combined with clinical neurological tests can be used to 
detect altered somatosensory function in PFPS subjects. Sensory assessments of PFPS 
patients indicate that the pain can have a pathophysiological component. 
 Somatosensory dysfunctions related to the painful and contralateral areas indicate 
modulations of central neural mechanisms.  
 Ample signs of sensory aberrations related to the painful area were found but a clear 
subgroup of subjects with neuropathic pain could not be identified.  
 Mental distress is higher and self-perceived health is lower in PFPS patients than in 
healthy controls. Further, the intensity of knee pain and degree of knee function are 
strongly correlated with the degree of mental distress. 
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1 Introduction 
1.1 Patellofemoral pain syndrome  
Patellofemoral pain syndrome (PFPS) is a descriptive diagnosis characterized by long-term 
anterior knee pain. The pain is not constant, instead varying with the type and level of 
activity. Several names have been used to denote the syndrome, including chronic anterior 
knee pain, idiopathic anterior knee pain, patellalgia, patellofemoral malalignment, patella 
compression syndrome and chondromalacia patella (Naslund 2006), however, PFPS is the 
term used by most authors (Arroll et al. 1997;Heintjes et al. 2003). 
 
1.2 Incidence of patellofemoral pain syndrome 
Many authors claim that PFPS is one of the most common musculoskeletal disorders 
(Lindberg et al. 1986;Milgrom et al. 1991;Kannus et al. 1999;Bergman et al. 2001;Tallay et al. 
2004), and that it tends to affect active young people (Saxena and Haddad 2003) and 
adolescents (James 1979). Others state that the condition is more common among active 
females (Sathe et al. 2002) and athletes (Earl et al. 2004). Many authors have reported on 
the occurrence of PFPS in a given population, with several authors reporting its occurrence 
in one-fourth of the general or sporting population (McConnell 1996;Brechter and Powers 
2002;Anderson and Herrington 2003;Ireland et al. 2003;Witvrouw et al. 2003). However, the 
reported prevalence is often based on unclear original data sources. A recent study claims 
that the estimated incidence or prevalence of PFPS in the adult general population is based 
almost entirely from source data from sports-medicine or military settings, and hence that 
the incidence of PFPS in the general population is not known (Callaghan and Selfe 2007).  
 
1.3 Symptoms and signs of patellofemoral pain syndrome 
There is no consensus in the medical literature concerning the definition, aetiology, and 
diagnosis of PFPS (Arroll et al. 1997;Wilk et al. 1998;Blond and Hansen 1998). Most studies 
describe symptoms of insidious onset, such as diffuse peripatellar and retropatellar localized 
pain in one or both knees that is aggravated by walking uphill or downhill, squatting, 
kneeling, or by prolonged sitting with flexed knees (Reid 1993;Arroll et al. 1997;Bizzini et al. 
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2003). There is reportedly no correlation between the pain intensity and the range of knee 
extension or flexion, femoral rotation, or quadriceps angle (Galanty et al. 1994). Clinical tests 
used to assess patients with PFPS have been shown to lack reliability and validity (Caylor et 
al. 1993;Fitzgerald and McClure 1995;Watson et al. 1999;Powers et al. 1999). Radiographic 
findings are inconclusive in diagnosing PFPS, but they can be used in a differential diagnosis 
(Haim et al. 2006). Here we define PFPS as a descriptive diagnosis characterized as anterior 
knee pain excluding intra-articular pathology, peripatellar tendonitis and bursitis (Reid 
1993). 
 
1.4 Aetiology of patellofemoral pain syndrome 
Research into the aetiology of pain in PFPS has concentrated on finding biomechanical 
causes.  However, several observations indicate an involvement of the peripheral nervous 
system around the patellae (Fulkerson et al. 1985;Mori et al. 1991). Increased levels of 
substance P are found near the patella, and histological samples have shown that 
involvement of the nervous system is strongly correlated with the pain experienced (Yaksh 
1988;Wojtys et al. 1990;Sanchis-Alfonso et al. 1998;Witonski and Wagrowska-Danielewicz 
1999). Baker et al. (2002) reported abnormal knee-joint position sensing in individuals with 
PFPS, which mignt reflect dysfunction of the neuromuscular system. Differences found in 
skin temperature between painful and normal knees might indicate involvement of the 
sympathetic nervous system (Ben-Eliyahu 1992), a notion supported by a significant 
correlation between reduced bone mineral density and reduced strength of the quadriceps 
in the same leg (Leppala et al. 1998). Reduced patellar pulsatile blood flow (Naslund et al. 
2007) and increased diffuse uptake on bone scintigrams (Naslund et al. 2005) might also be 
indicative of dysfunction of the sympathetic system. The presence of long-lasting anterior 
knee pain appears to be correlated with reduced strength of and altered recruitment pattern 
in the quadriceps in the same leg (Natri et al. 1998;Cowan et al. 2001). This could be related 
to the neurological-based flexion reflex involving reciprocal inhibition of the extension 
muscles (i.e. the quadriceps) in the leg (Stokes and Young 1984a;Stokes and Young 
1984b;Leroux et al. 1995;Andersen et al. 2000). These reports indicate a possible 
neurophysiologic substrate for clinical signs and symptoms evident in PFPS.  
Few studies have assessed the relationship between sensory function and knee pain. Such 
assessments can utilize quantitative sensory testing (QST), a psychophysical method widely 
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accepted in evaluating the function of small nerve fibres (Fruhstorfer et al. 1976;Claus et al. 
1987;Yarnitsky and Ochoa 1991;Dyck et al. 1993;Yarnitsky et al. 1995;Yarnitsky 1997;Shy et 
al. 2003). Conventional EMG and neurographic investigations test the conduction of nerve 
signals in thicker myelinated nerves, and can therefore not be used to assess the function of 
small-diameter pain-conducting fibres such as C and Aδ (delta) fibres. However, 
interpretations of the results from the QST must consider the limitations of subjective 
evaluation of sensation (Shy et al. 2003).  
 
1.5 Treatment of patellofemoral pain syndrome 
Few controlled trials have investigated the treatment of PFPS. The review by Arroll et 
al.(1997) found only five studies meeting their criteria. Two controlled trials administering 
intraarticular or intramuscular injection of glycosaminglycan gave conflicting results 
(Raatikainen et al. 1990;Kannus et al. 1992). Eng and Pierrynowski (1993) found that insoles 
with hindfoot and forefoot wedging were superior to flat insoles in reducing knee pain after 
8 weeks of use, and Finestone et al.(1993) found that an elastic knee sleeve had no effect. A 
later review of non-surgical and non-pharmacological interventions concluded that there is 
only weak evidence that physical interventions are effective in managing PFPS (Crossley et 
al. 2001). The evidence that exercise therapy is more effective than no exercise at reducing 
pain is weak and conflicts with observed functional improvements (Heintjes et al. 2003). 
Moreover, there is little evidence of the effectiveness of non-steroidal anti-inflammatory 
drugs (NSAIDs) for short-term pain reduction in PFPS (Heintjes et al. 2004), or supporting the 
use of braces or surgery (Dixit et al. 2007). The most recent systematic review by Bizzini et al. 
(2003) used a grading scale to judge the quality of randomized clinical trials of non-operative 
treatments for PFPS. This review gave Paper I of this thesis the highest score based on the 
quality of methodology, and the assessment of outcomes favoured acupuncture as a 
treatment modality in PFPS.  
 
1.6 Sensory considerations 
There is reportedly marked variability in the distribution and consistency of several articular 
nerves to the knee. Kennedy et al.(1982) described two consistently distinct groups of 
afferent articular nerves: (1) a posterior group including the posterior articular and obturator 
nerves and (2) an anterior group consisting of articular branches of the femoral (L1–4), 
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common peroneal (L4–S2) and saphenous nerves, and which supplies the anteriomedial and 
anteriolateral capsules and associated ligaments. These nerves are located deep to the 
medial and lateral retinaculum. Three articular afferents form the terminal branches of the 
femoral nerve supplying the quadriceps muscle. The lateral articular and recurrent peroneal 
nerves originate from the common peroneal nerve and supply the inferior portion of the 
lateral capsule and ligament. The infrapatellar branch of the saphenous nerve supplies the 
inferomedial portion of the capsule, patellar tendon and the skin overlying the medial aspect 
of the knee (Kennedy et al. 1982). Two cutaneous nerves coursing within the substance of 
the vastus medialis and lateralis reach the patella at the superomedial and superolateral 
edges to innervate the skin covering the 
patella (Maralcan et al. 2005;Nahabedian 
2006) (see Figure 1). The cutaneous sensory 
innervation of the medial aspect of the knee 
includes – in addition to the infrapatellar 
branch of the saphenous nerve – the medial 
and anterior cutaneous nerve of the thigh. 
The lateral aspect of the knee includes the 
tibiofibular branch of the peroneal nerve 
and the lateral femoral cutaneous nerve. 
The superficial nerves are located in the 
subcutaneous fat (Nahabedian and Johnson 
2001).                      Figure 1. Sensory nerves   (Nahabedian 2006, p.364, Fig. 23.1) 
 
1.7 Anatomical and physiological aspects of pain 
Nociceptors are defined as sensory receptors signalling ongoing tissue damage or that injury 
is about to occur (Sherrington 1906). Nociceptive fibres for perceiving pain are in this thesis 
categorized according to fibre type (C and Aδ) and responsiveness to thermal and 
mechanical stimuli. Myelinated nociceptive A-fibres are responsible for sharp, pricking, first 
pain and are mainly Aδ fibres with a conduction velocity of 2–30 m/sec (Adriaensen et al. 
1983;Meyer et al. 2006). Sustained burning pain and second pain sensation are mainly 
conveyed by thin unmyelinated C-fibre nociceptors, with a conduction velocity of <2m/sec 
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(Meyer et al. 2006). The Aβ (beta) sensory fibres are cutaneous mechanoreceptors and 
convey innocuous information about touch and vibration (Campbell et al. 1979;Bromm and 
Treede 1991).  
The dorsal part of the spinal cord is the sensory component receiving terminal central 
rootlets of the primary afferent fibres from the periphery. (see Figure 2). The grey matter of  
 
   Figure 2. Sensory fibres in dorsal horn. 
Schematic representation of the general properties of cutaneous afferent fibres. Inequality signs denote the relative 
numbers of afferent fibres within a conduction pathway that respond to innocuous (blue) or noxious (grey) stimuli. The 
density of the terminals of each type of fibre is indicated by the degree of stippling within each projection zone. Note that 
not all C fibres are nociceptors, and not all Aβ fibres are low-threshold mechanoreceptors (CLTMR). HTMR, high-threshold 
mechanoreceptors. 
 
the dorsal horn is divided into different laminae, from lamina I (superficial) to lamina V 
(deepest). Primary afferent Aβ fibres terminate mainly in lamina III and IV, nociceptive Aδ 
fibres terminate mainly in laminae I,II and V, and C fibres terminate mainly in lamina II 
(substantia gelatinosa) (Todd and Koerber 2006). The main ascending somatosensory 
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systems consist of the dorsal-column lemniscal system and the spinothalamic system. (see 
Figure 3). The thermal, tactile and vibration QST used in the studies reported in this thesis 
assesses function mainly in these sensory pathways. The dorsal-column lemniscal system 
serves mechanoreception, such as tactile recognition, detection of vibration and 
proprioception. The spinothalamic tract is the pathway most closely associated with 
thermoreception (both cold and heat), nociception and visceroception. Nociceptive tracts 
found in the spinal white matter (in addition to the spinothalamic tract) are the 
spinomedullary, spinobulbar and spinohypothalamic tracts. Projections from high threshold 
nociceptive neurons in lamina I and multireceptive neurons (with a wide dynamic range) in 
lamina V ascend mainly via the spinothalamic tract (the extralemniscal system) to the ventral 
posteriolateral nucleus in the thalamus. The fourth-order neurons of both systems originate 
in the thalamus and project into the network of somatosensory cortex areas, which include 
the primary and secondary somatosensory cortex, posterior parietal cortex and posterior 
and mid-insula and mid-cingulate cortex (Dostrovsky and Craig 2006;Treede 2007).  
 
       Figure 3. Sensory pathways. 
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1.8 Pain classification 
The International Association for the Study of Pain (IASP) defines pain as “an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or 
described in terms of such damage”. Pain can be described as either nociceptive or 
pathophysiological (Devor 2006) (see Figure 4). Both long-term inflammation and nerve 
dysfunctions can give rise to pathophysiological pain. Pain generated partly or exclusively  
 
Figure 4. Classification of pain. 
 
 
 
 
 
 
 
 
 
 
 
within the nervous system without adequate stimulation of its peripheral sensory endings 
has up to recently been termed neuropathic pain, and defined by the IASP as “pain initiated 
or caused by a primary lesion or dysfunction in the nervous system” (Merskey and Bogduk 
1994). The following revised definition has recently been proposed by a group of experts 
from the neuropathic pain special interest group (NeuPSIG) of the IASP:“pain arising as a 
direct consequence of a lesion or disease affecting the somatosensory system” (Treede et al. 
2007). This more-specific definition was needed to distinguish between pain due to 
secondary neuroplastic changes in the nociceptive system resulting from sufficiently strong 
nociceptive stimulation (i.e. inflammatory musculoskeletal pain) and other types of pain that 
arise indirectly during the course of neurological disorders. That group proposed a grading 
system using the following criteria: “1. Pain with a distinct neuroanatomically plausible 
distribution (like dermatome). 2. A history suggestive of a relevant lesion or disease affecting 
the peripheral or central somatosensory system (like polyneuropathy, apoplexia). 3. 
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Demonstration of the distinct neuroanatomically plausible distribution by at least one 
confirmatory neurological clinical or laboratory test. 4. Demonstration of the relevant lesion 
or disease by at least one confirmatory neurological clinical or laboratory test”. Gradings of 
definite neuropathic pain (all four criteria), probable neuropathic pain (criteria 1 and 2, plus 
either criterion 3 or 4), and possible neuropathic pain (criteria 1 and 2, without confirmatory 
evidence from criterion 3 or 4) have been proposed (see Figure 5, from Treede et al. 2007). 
The grade of possible neuropathic pain can only be regarded as a working hypothesis that 
does not exclude but does not diagnose neuropathic pain. The grades of probable 
neuropathic pain and definite neuropathic pain both require confirmatory evidence from 
additional neurological examinations.  
 
Figure 5. Classification of neuropathic pain. 
 
 
This thesis uses the revised grading system to define neuropathic pain. The term 
pathophysiological pain is used to describe pain that is possibly due to dysfunction or plastic 
changes in the nervous system (see Figure 4). 
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1.9 Psychological considerations 
Patients with PFPS experience periods with severe and increased pain during and after 
activity, often without any physical findings that could explain the pain. This situation can be 
frustrating for both patients and therapists. The absence of physical findings that explain the 
pain can lead to speculation that the pain is not real or that it is psychological or 
exaggerated. Patients with PFPS often suffer for several years with their complaint. If 
patients with PFPS also suffer from depression, anxiety and somatization, or their ability to 
perform and adapt to their given environment is impaired, these factors should be taken 
into consideration when designing a treatment regime. Psychological variables and those 
describing self-perceived health statuses have received little attention in PFPS research, and 
we know of no personality or emotional characteristics that have higher prevalence rates in 
PFPS patients. Although clinical trials of subjects with PFPS have not assessed psychosocial 
aspects, four studies have addressed the mental state of patients with PFPS (Carlsson et al. 
1993;Witonski 1999;Witvrouw et al. 2000;Thomee et al. 2002). These studies concluded that 
individuals with PFPS suffer both mentally and physically. Three of these studies included 
subjects suffering from long-term PFPS (Carlsson et al. 1993;Witonski 1999;Thomee et al. 
2002) and one was a prospective study (Witvrouw et al. 2000). The Minnesota Multiphasic 
Personality Inventory (the 566-question version) and the Rorschach test were used as the 
main tools in two of the studies to assess the psychological state of the subjects (Carlsson et 
al. 1993;Witonski 1999). Analysing the data obtained with these psychological instruments 
requires specialized knowledge and experience, making them less useful in a normal clinical 
setting, which requires instruments that are easy to use and that produce results that are 
easy to analyse. 
 
1.10  Somatosensory stimulation 
Studies have shown that cutaneous afferent stimulation by the application of inelastic tape 
on the skin in the painful area induces short term pain reduction in PFPS patients (Salsich et 
al. 2002;Whittingham et al. 2004;Aminaka and Gribble 2005;Aminaka and Gribble 2008) and 
improvement in motor function of the vasti musculature of the thigh (Macgregor et al. 
2005). Transcutaneous electric stimulation to the skin in the painful area also reduces pain 
and improve motor function in PFPS subjects (Werner et al. 1993;Callaghan and Oldham 
2004;Avraham et al. 2007). The exact mechanism underlying this effect is not known. 
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Pain is the main symptom in PFPS; and hence its treatment modalities should reduce pain. 
Acupuncture treatment is increasing in popularity in mainstream health care, and is the 
complimentary systems that enjoys the highest credibility in the medical community (Astin 
et al. 1998;Kaptchuk 2002;Weidenhammer et al. 2007;Bucker et al. 2008). The original 
underlying therapeutic theory or conceptual framework of acupuncture differs radically from 
that of biomedicine, since it is based on traditional Chinese medicine (TCM). However, 
modern research has shown that acupuncture stimulates the nervous system by activating 
the Aβ, Aδ and C afferent fibres, with the induced signals ascending mainly through the 
spinal ventrolateral columns to the brain. Several brain nuclei constituting a complicated 
network are involved in the underlying processing of acupuncture analgesia, including the 
nucleus raphe magnus, periaqueductal grey, locus coeruleus, arcuate nucleus, preoptic area, 
nucleus submedius, habenular nucleus, nucleus accumbens, caudate nucleus, septal area 
and the amygdala (Zhao 2008). Recent studies of the neural mechanisms underlying 
acupuncture analgesia have predominately focused on cellular and molecular contributions. 
The gate control theory of pain and the endorphin theory have been used to explain the 
effects of acupuncture stimulation on pain (Andersson and Lundeberg 1995;Kaptchuk 2002). 
Various endogenous opioids such as β endorphin, enkephalin and dynorphin have later been 
documented to be involved in electroacupuncture analgesia. This working hypothesis about 
the role of endogenous opioids in acupuncture action has been widely accepted (Han 2004). 
The effect of acupuncture on pain has also been explained through diffuse noxious inhibitory 
control (DNIC) (Le Bars D. et al. 1992).  
Other possible reasons for pain relief induced by acupuncture are disassociation of the 
sensation of pain and the emotional distress that it normally causes, with patients being less 
bothered by the pain. Such psychological reactions are believed to be induced by stimulation 
of the limbic-paralimbic-neocortical network (Campbell 1999;Pilkington et al. 2007;Fang et 
al. 2008). Recent clinical studies have indicated a psychological effect of acupuncture on 
patients suffering from depression and anxiety (Luo et al. 1998;Pilkington et al. 2007;Leo and 
Ligot, Jr. 2007;Fu et al. 2008;Lu et al. 2008). 
Both pain and nociceptive reflexes in the flexor muscles of the knee might be affected via 
the same central mechanisms (Lewith and Machin 1983;Le Bars D. et al. 1992;Mense 
1993;Andersson and Lundeberg 1995). Activation of centrally modulated reflex activity has 
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been suggested to inhibit and disturb recruitment patterns of the vasti in the quadriceps 
muscle of PFPS subjects (Herrington 2001;Herrington 2004).  
The above factors were addressed by the studies described in this thesis, also considering 
whether somatosensory stimulation by acupuncture can benefit PFPS patients by reducing 
pain, improve function and mental status.  
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2 Objectives 
 
2.1 General aims: 
This thesis aims to deepen the understanding of PFPS. The described studies focused on 
evaluating the effect of somatosensory stimulation by acupuncture, assess sensory function 
related to the painful knee, and relating mental status to function and pain in subjects with 
PFPS. 
 
2.2 Aims and hypotheses: 
2.2.1 Paper I 
In a well-defined group of subjects with PFPS, the hypothesis in Paper I was that knee 
function and pain would not differ up to 12 months after eight sessions of semi-standardized 
acupuncture treatment compared to before treatment. We aimed to evaluate any added 
effect of acupuncture treatment on a defined group of patients with PFPS who had not 
previously improved with recommended periods of rest and traditional treatment. 
 
2.2.2 Paper II 
The hypothesis in Paper II was that mental distress and self perceived health differ between 
subjects with long-term PFPS and healthy controls, and that these psychological variables 
are related to knee pain and function. We aimed to assess the psychological and general 
functional state of subjects with PFPS by using the Hopkins Symptoms Checklist-25 (HSCL-25) 
questionnaire and COOP-Wonca charts, with the aim of identifying relationships of these 
psychological parameters with knee pain and function. 
 
2.2.3 Paper III 
The hypothesis in paper III was that functioning related to somatosensory pathways from 
the painful area differs between subjects with PFPS and healthy subjects. We aimed to use 
thermal and tactile QST to detect possible sensory nerve dysfunctions related to the painful 
area in subjects with long-term PFPS. 
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2.2.4 Paper IV 
The hypothesis in Paper IV was that signs and symptoms clearly related to neuropathic pain 
are more prevalent among PFPS patients than among healthy controls. We aimed to assess if 
a subgroup of patients with PFPS suffers from neuropathic pain related to the painful knee 
based on the results of QST, bedside neurological tests and anamnestic data. 
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3 Methods 
 
In the four studies that form Papers I-IV of this thesis the symptoms of PFPS were 
caracterized as being of insidious onset, such as diffuse peripatellar and retropatellar 
localized pain in one or both knees that is aggravated by walking uphill or downhill, 
squatting, kneeling or by prolonged sitting with flexed knees (Reid 1993;Arroll et al. 
1997;Bizzini et al. 2003). The materials and methods used are described in detail in the 
original articles, and methodological considerations are discussed in Section 8.  
 
3.1 Subjects 
3.1.1 Paper I 
The sample for Study 1 (described in Paper I) consisted initially of 75 participants with PFPS. 
Five subjects (4 in the control group and 1 in the acupuncture group) withdrew before the 
first follow-up, and hence this study involved 70 subjects (sample A), comprising 41 females 
and 29 males aged 18 to 45 years, with a mean age of 31.0 years. Subjects were recruited 
from orthopaedic outpatient departments at local hospitals, from private physiotherapy 
clinics and by advertisements in a local newspaper in Bergen, Norway. Thirty-six and 34 
patients were randomized into the treatment and control groups, respectively. Table 1 in 
Paper I lists the demographics background data of the participants. Subjects were included if 
they experienced anterior knee pain in one or both knees during activity or at rest. 
Information from the medical history had to be consistent with the description of PFPS, with 
no other more-specific knee disorder being diagnosed or found at inclusion. Subjects who 
had received acupuncture within the previous 12 months or steroid treatment within the 
previous 3 months were excluded. Included patients had to be able to participate in the 
normal activities of daily life.  
 
3.1.2 Papers II and III 
Twenty-seven subjects with PFPS applied for inclusion in the studies for Papers II and III, of 
which 25 (16 females and 9 males) aged 19–44 years, with a mean age of 32 years, met the 
inclusion criteria (sample B). PFPS subjects were recruited from orthopaedic outpatient 
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departments at local hospitals, from private physiotherapy clinics and by advertisements in a 
local newspaper in Bergen, Norway. Inclusion and exclusion criteria for the PFPS group are 
listed in Table 1 in Paper II, and background data are presented in Table 2 in Paper II and in 
Table 4 in Paper III. A group of control subjects with healthy knees (sample C) consisted of 12 
females and 11 males aged 18–44 years, with a mean age of 29 years. These healthy controls 
consisted both of colleagues of the authors and volunteers unfamiliar to the authors. 
Inclusion criteria for the healthy controls are presented in Table 1 in Paper II. 
 
3.1.3 Paper IV 
Study 4 included 91 subjects with unilateral PFPS (sample D), consisting of 56 males and 35 
females aged 18–40 years, with a mean age of 31 years. Table 2 in Paper IV lists further 
background data of the PFPS subjects. Inclusion and exclusion criteria for the PFPS group are 
listed in Table 1 in Paper IV (see errata: Correction of age range: 18–44 years). Subjects were 
recruited from orthopaedic outpatient departments at local hospitals, from private 
physiotherapy clinics and by advertisements in a local newspaper in Bergen, Norway. The 
healthy control group consisted of sample C, also used as the control group in Studies 2 and 
3. 
 
3.2 Designs 
3.2.1 Paper I 
This study was designed as an experimental controlled trial in which the included 
participants were randomized into blocks of four to receive acupuncture treatment or no 
acupuncture treatment. Information from both the medical history and clinical examinations 
was used to confirm compliance with the inclusion and exclusion criteria. The study used an 
independent blinded tester (S.F.), and the participants were blinded for the outcome 
measurements. Subjects were allowed to receive normally recommended treatments other 
than acupuncture, but none of them did so. The acupuncture treatment was based on an 
individual diagnosis of each patient based on TCM criteria. The NNT was used to measure 
treatment efficacy. Parametric and non-parametric statistical tests were used to evaluate 
differences. 
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3.2.2 Papers II - IV 
A descriptive design that including two independent samples was used in Studies 2–4. 
Differences between the two groups in these case–control studies were assessed using 
parametric and non-parametric statistical tests. The age, gender and body mass index (BMI) 
did not differ significantly between the groups in each study. Conclusions about the groups 
were based on differences and associations between variables measuring knee pain, knee 
function, mental state and somatosensory function. This design was chosen since it is 
cheaper, quicker and usually smaller than alternative epidemiological designs, such as cohort 
studies. 
 
3.3 Clinical neurological examinations (Papers III and IV) 
A bedside neurological assessment of the reflexes of adductors and the patella and Achilles 
tendons, hypo/hyperaesthesia, hypo/hyperalgesia and allodynia of the skin in the knee area 
was performed on all PFPS subjects. Muscles identified relative to peripheral and segmental 
(root) nerves in the lower extremities were tested manually for strength. Positional 
sensations of the knee, ankle and big toe were assessed by passively flexing or extending the 
joints of the non-painful leg and asking the subjects to actively place the same joint in the 
painful leg in the same position whilst the eyes were closed. In Study 3, vibration sensation 
was assessed by applying a tuning fork (Hartman, 256 Hz) to the knee and ankle. A soft brush 
and a steel pinwheel (Wartenberger) were used to identify qualitative differences in skin 
sensitivity and pain perception between the painful and pain-free lower extremities. When 
sensation was perceived as being stronger in the non-painful knee than in the painful knee, 
this was recorded as hypoaesthesia of the painful knee. If the opposite was found, this was 
recorded as hyperaesthesia of the painful knee. An electric toothbrush (Braun) was used in 
attempts to provoke dynamic mechanical allodynia in the painful area (Eide and Rabben 
1998). 
 
3.4 Quadriceps atrophy (Papers I, III, IV) 
Atrophy of the quadriceps muscle was assessed by using a tape measure to measure the 
circumference at 5 cm proximal to the superior border of the patella. A difference 
(reduction) between the legs of at least 2 cm was classified as atrophy (Hoppenfeld 1976). 
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3.5 Questionnaires 
3.5.1 Cincinnati Rating System (Papers I, II and IV) 
The knee function during the 2 weeks prior to the test day was assessed with the Cincinnati 
Rating System (CRS) self-administered questionnaire (Noyes et al. 1984). This is a numerical 
scale that evaluates symptoms of pain (20 points), swelling (10 points), giving-way (20 
points) and function 50 points (overall activity level (20 points), walking (10 points), stairs (10 
points), running activity (5 points), jumping and twisting activities (5 points), giving a 
maximum score in the absence of symptoms and signs of 100 points. This questionnaire has 
been shown to be valid in assessing patients with chronic knee pain (Barber-Westin et al. 
1999;Marx et al. 2001), and has been translated into Norwegian and validated (Risberg et al. 
1999).  
 
3.5.2 COOP-Wonca charts (Paper II) 
COOP-Wonca charts are designed to measure functional or self-perceived health status 
during the previous 2 weeks. This instrument comprises six scales that assess the level of 
physical fitness, feelings or emotional problems, ability to carry out daily activities, social 
activities, changes in health, and overall health. Scores range from 1 (best score) to 5 (worst 
score). The chart is commonly used in primary health care research. It has been translated 
into more than 20 languages, with the Norwegian version having been tested and validated 
(Bentsen et al. 1997;Holm et al. 2005).  
 
3.5.3 Hopkins Symptom Check list -25 (Paper II) 
The HSCL-25 questionnaire is a shorter version of the Hopkins Symptoms Checklist. It 
consists of 25 items measuring the degree of mental distress on a scale from 1 (none) to 4 
(very high) for the previous 2 weeks. The HSCL-25 is a screening instrument designed to 
identify common psychiatric symptoms in the areas of anxiety and depression. The 
questionnaire has been found to be valid and reliable, and enables differentiation between 
populations comprising healthy subjects and neurotic patients (Derogatis et al. 
1974;Nettelbladt et al. 1993;Rognerud et al. 2002;Strand et al. 2003). A mean score greater 
than 1.75 indicates a psychiatric case in need of treatment (Derogatis et al. 1974;Glass et al. 
1978;Nettelbladt et al. 1993). The questionnaire has been translated into Norwegian, and 
applied to Norwegian subjects (Sandanger et al. 1998). 
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3.6 Functional tests  
In addition to symptoms and signs, functional performance tests should be used when 
assessing individuals with PFPS. Functional performance tests specific to PFPS should include 
weight-bearing activities with various knee-flexion angles so as to include positions that 
commonly aggravate pain and require dynamic muscular control (Loudon et al. 2002). Pain 
experienced during testing is not measured directly, but it will influence the result of the 
test. 
3.6.1 Stairs hopple test (Paper I) 
The stairs hopple test (Risberg et al. 1995) was applied with the patients jumping on one leg 
up and down 12 steps, each step 17 cm high. The best leg was tested first. The time to 
complete the test on each leg was measured in tenths of seconds, with a lower value 
indicating better performance. The results of this test are strongly correlated with scores on 
the Lysholm scale and the CRS (Hoher et al. 1995;Risberg et al. 1995). 
3.6.2 Triple jump test (Paper II) 
The triple jump test has been described by Risberg et al. (1995). It was chosen for Study 2 
because it is easy to perform, time efficient and needs minimal instruction and no expensive 
test equipment. The triple jump test is a functional test that mimics the functional demands 
of weight-bearing and jumping (Risberg and Ekeland 1994;Risberg et al. 1995). Standing on 
one foot, the subjects jumped three times on the same lower extremity along a straight line. 
This procedure was performed twice for each lower extremity, first on the pain-free lower 
extremity, and then on the lower extremity with the painful knee. The higher score of the 
two attempts was noted for each lower extremity. The difference between the lower 
extremities in the distance travelled (in centimetres) was recorded as the final score. 
3.6.3 Step-down test (Paper IV) 
Loudon et al. (2002) found the step down test to be the most sensitive and reliable of five 
assessed performance tests, with it being the only test that discriminated between PFPS 
patients and normal controls (p<0.013). In the step down test, the subjects stand on one leg 
and step towards the floor from a platform 20cm higher than the floor. The down-moving 
limb only touches the floor with the heel and then returns to full knee extension of both 
legs. This counts as one repetition, and the number of repetitions the subject performed in 
30 sec is recorded. Both lower extremities are tested (Loudon et al. 2002).  
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3.7 Pain 
3.7.1 Visual analogue scale (Papers I-IV) 
A visual analogue scale (VAS) consisting of a 100-mm-long horizontal line was used to 
measure the intensity of knee pain both during the week prior to test day and on the day of 
testing. The left side of the line indicates no pain (0 mm) and the far right represent 
intolerable pain (100 mm). The subjects indicated the intensity of pain they experienced by 
marking the line, from no pain (left end, 0 mm) to intolerable pain (right end, 100 mm). The 
VAS score was quantified as the distance in millimetres from the left end. The VAS has been 
documented as being both reliable and appropriate for measuring pain (Price et al. 1983), 
and is widely used when investigating subjects with knee pain (Chesworth et al. 1989;Flandry 
et al. 1991;Harrison et al. 1995). Additionally, pain was recorded and characterized according 
to qualities associated with neuropathic pain conditions (Hanson 1997;Bouhassira et al. 
2005). 
 
3.8 Quantitative sensory testing 
QST was used to assess functioning related to Aβ, Aδ and C-fibres and the spinothalamic and 
dorsal-column sensory pathways. The test procedure used is described in the methods 
section of Papers III and IV. 
3.8.1 Tactile sensation (Papers III and IV) 
Von Frey filaments were used to test low threshold mechanoreception in the painful area. 
Testing with von Frey monofilaments is simple in clinical practice and gives reliable and valid 
results (Weinstein 1962;Bell-Krotoski and Tomancik 1987;Waylett-Rendall 1988;Voerman et 
al. 1999;Mikkelsen et al. 2004;Keizer et al. 2007). Moreover, tactile sensation reflects the 
function of mechanoreceptors and myelinated Aβ fibres with their central connections (Hilz 
et al. 1995). 
3.8.2 Vibration (Paper IV) 
The force of the probe on the skin was calibrated to approximately 650g, with a vibration 
frequency of 100Hz. Results are expressed as the displacement of tissue (skin deformation) 
in microns. This was found to be an adequate stimulus for Pacinian corpuscles, the main type 
of mechanoreceptors responding to innocuous stimuli above 65Hz, and the most sensitive 
between 125 and 250Hz (Goldberg and Lindblom 1979;Laursen et al. 2006). Vibration 
31 
sensation reflects the function of mechanoreceptors and myelinated Aβ fibres with their 
central connections (Hilz et al. 1995). 
3.8.3 Thermal sensation (Papers III and IV) 
The heat detection threshold is commonly used to assess the function of unmyelinated C 
fibres with their central connections. The cold detection thresholds is used to assess the 
function of myelinated Aδ fibres, and to a lesser extent that of subgroups of C fibres 
(Verdugo and Ochoa 1992;Campero et al. 1996). The test algorithm of the thermotesting 
used in this study followed that recommended by Hilz et al. (1999). The sum of heat and cold 
detection thresholds (limen) was also calculated (Fruhstorfer et al. 1976). 
 
3.9 Somatosensory stimulation 
3.9.1 Acupuncture (Paper I) 
The acupuncture treatment was based on an individual acupuncture diagnosis from 
Traditional Chinese Medicine (TCM). In accordance with theories of TCM the PFPS subjects 
were classified into the following four diagnostic types based on the predominant symptoms 
and signs: Cold-Bi (painful Bi), Damp-Bi (fixed Bi), Wind-Bi (wandering Bi) and Heat-Bi (febrile 
Bi) (International Acupuncture Training Centre 1988). Subjects in the acupuncture group 
were needled locally at ST-34 and SP-10, and also at either EX-LE5 and ST-35 or SP-9 and ST-
36. Other points used depending on the symptoms and signs in individual subjects were BL-
17, BL-18, BL-20, BL-23; LI-4 and CV-4 (International Acupuncture Training Centre 1988). The 
applied manual stimulation included lifting, thrusting and rotating techniques. Five patients 
diagnosed as Cold-Bi with intense local knee pain received low frequency (3 Hz) 
electroacupuncture. Moxa stimulation was not used since it was impractical. The 
acupuncture treatment was repeated twice weekly for 4 weeks. Each session lasted 20-25 
minutes, and the needles (sterile disposable stainless steel, gauge 0.28; Cloud & Dragon, 
Wujian Acupuncture Needle Factory, Jiangsu Province, China) were initially manipulated 
until the needling sensation described as ‘De-Qi’ was obtained. The insertion-depth varied 
from 2 to 4 cm. The operator (the candidate) is a qualified traditional acupuncturist with 25 
years of clinical acupuncture experience 
  
32 
4 Ethical considerations 
 
There are ethical considerations in all studies involving people. Respecting the integrity of 
participants is imperative, and the way an informant is approached, informed and managed 
throughout the research process must follow ethical considerations. The benefit of obtaining 
new knowledge through research must be weighed against any possible harm to the 
participants. Procedures used in the research process might provide few health benefits to 
those participating in the research. Since the focus of the researcher is normally not on 
improving the health of the participant, detailed information about the procedures used in 
the study should be given. The Helsinki Declaration makes it imperative to obtain informed 
consent from all participants in medical research, and care must be taken to ensure that the 
participants are capable of giving an informed consent. Children and senile, mentally ill or 
critically ill adults all require extra attention due to limitations in their ability to provide 
informed consent. All of the studies reported in this thesis included only persons aged 18 to 
45 years with no history of mental illness. 
Three dimensions related to personal integrity and consent in research are often considered 
when assessing the participant’s right to make a decision: (1) when the participant’s body is 
involved, (2) when material that originates from the participant’s body is involved and (3) 
when information given by the participant is used. Written consent must be obtained from 
participants in research involving any of these dimensions. In my view, the need for 
informed consent should be graded according to which dimension of involvement the 
participants accept. Clearly, the need for strong rules regarding consent must be followed 
when the research involves invasive procedures or the use of biological material from the 
participants. However, the integrity of the participants is not threatened in large 
epidemiological studies that collect and analyse already-collected health information. In this 
situation low health risk and the potentially significant benefit to society mean that a lower 
level of consent might be acceptable. The rules of consent should be balanced between 
avoiding unnecessary research hindrance and ensuring the safety and integrity of the 
participants. In this project, the healthy control group (sample C) was recruited for Studies 2 
and 3, and their data were also used as a healthy control group in Study 4. 
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Accepted clinical examinations related to the issues under investigation were used, and 
standard questionnaires and non-invasive procedures with normal stimuli were applied 
when assessing sensory functions. The thermotester used was controlled and tested at the 
Department of Medical Technology, Haukeland University Hospital, Bergen, Norway, and 
calibrated by the manufacturer. Acupuncture is regarded as a safe procedure for sensory 
stimulation with little or no side effects provided that the treatment is performed by trained 
practitioners (Macpherson et al. 2001;Odsberg et al. 2001;White et al. 2001a;Macpherson et 
al. 2004).  
The literature reviews confirmed the need for more research into PFPS. Future patients will 
benefit if the obtained results give therapists a better understanding of the aetiology of the 
syndrome, resulting in more evidence-based treatments being applied. Moreover, the 
results obtained from the collected data might give some of the informants more knowledge 
about their own condition. 
Ethical concerns were addressed by the written information given to the participants. Issues 
regarding confidentiality and the right to withdraw from the project were clearly stated. The 
purposes of the studies were also explained to the informants. There were no reasons to 
expect inconvenience or any harm to the participants either during the project or thereafter. 
Issues concerning PFPS are not controversial, and hence it was not necessary to invade the 
privacy of the informant, with only validated standard questionnaires being used. QST is an 
assessment that involves the application of normal non-painful stimuli. The informants were 
in control of the test situation throughout the procedures, and could at any time abort a 
particular test.  
The skill and professional background of the researcher is an ethical issue when considering 
the likely harm or benefit to the informer. The Health Personnel Law regulates the expected 
conduct of health personnel when they meet with patients as therapists or researchers. 
Ethical issues relating to confidentiality and professional background are also regulated by 
this law. The data-collection processes used in this project were close to the procedures 
used when I assess my patients as a therapist, and I am very familiar with PFPS in my 
practice. My supervisors of this project are also familiar with the condition, which has 
provided the benefit of maintaining the professionalism of the research process. 
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It would be unethical to invite subjects to participate in badly designed studies, and an 
accurate and honest analysis and careful interpretation is needed in balancing the benefits 
and burdens of a project. The quality of the results was secured by data registration being 
controlled by co-authors of the papers. It is an ethical obligation for researchers to publish 
the results of completed studies to inform colleagues about the results and to be challenged 
by other researchers.  
The studies described in this thesis complied with the latest revised edition of the Helsinki 
Declaration (http://www.etikkom.no/retningslinjer/helsinkideklarasjonen). 
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5 Statistics 
Background data of the participants in the studies are presented as mean, standard 
deviation (SD), range and percentage values. Statistical tests were two-sided and at the 5% 
level of significance. All data were analysed using the statistical software SPSS (Windows 
version).  
 
5.1 Paper I 
Calculations of statistical power conducted before commencing Study 1 showed that to be 
able to disclose a difference of 15 in the CRS score with 80% certainty, 27 patients were 
needed in each group, giving an estimated SD of 20, and =0.05 and =0.20. Differences in 
categorical scales were tested by the Mann-Whitney test. Differences in proportions were 
tested by chi-square tests. The CRS score, regarded as the main outcome measure, was 
analysed with non-parametric statistics both globally and on subscales. The results of the 
global scores were skewed, and the subscales were regarded as ordinal scales. Differences in 
continuous data, such as on the VAS, stairs hopple test and atrophy, were tested with 
Student’s t-test for independent samples between groups, and changes within a group were 
tested by a paired t-test. Treatment efficacy was calculated as the NNT (Sackett et al. 1997). 
We chose “no pain” or “occasional pain to strenuous sports” and “no limitations” or “some 
limitations to heavy labour” in the CRS as cut-offs indicating a clinically significant 
improvement. 
 
5.2 Paper II 
Due to the skewed distribution of the obtained data in Study 2, the independent two-sample 
Wilcoxon test was used for the continuous variables of age and BMI. Measures on the global 
CRS, COOP-Wonca charts, HSCL-25 and triple jump test were normally distributed, and 
hence differences in means between the groups were tested with Student’s t-test for 
independent samples. Since the outcome data had a normal distribution, Pearson’s 
correlation coefficient (r) was used to measure relationships between the measures: 
functional health status (COOP-Wonca charts), mental distress (HSCL-25), pain (VAS), knee 
function (CRS) and triple jump test.  
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5.3 Paper III 
Data from QST in Study 3 are presented as mean (±SD) values. Von Frey measurements are 
also presented as range and 95% confidence interval (CI) values, and we defined scores 
outside the range from 5–95% CI for the healthy controls as pathological (Orstavik et al. 
2004). Data from QST of the healthy control group are presented as the mean score 
between the right and left knees. Differences between the groups were tested using the 
Mann-Whitney U-test for continuous variables since the distribution were skewed, and 
differences within groups were tested with Wilcoxon’s signed-rank test. The chi-square test 
was used for categorical variables. 
 
5.4 Paper IV 
Data from QST in Study 4 are presented as medians, with the spread of the frequency 
distribution as interquartile ranges (from the 25th to the 75th percentile) in brackets. Medians 
were used rather than means since the data were skewed, and the cold pain thresholds of 
many of the participants were outside the cut-off (<7 C). The uneven distribution of the QST 
results was tested visually on quantile–quantile plots and with the Kolmogorov-Smirnov test 
(p>0.05). Hence, differences in continuous variables between the lower extremities of the 
PFPS subjects and between the groups were tested with non-parametric tests. Differences 
between the categorical variables were tested with the chi-square test. Correlation analyses 
were performed with Spearman correlation analysis, and factor analysis (with Varimax) was 
used to identify related continuous variables. In this study we calculated the normal range of 
the tactile and thermal thresholds to be within the 2.5th to 97.5th percentiles of the values of 
the healthy controls (Wright and Royston 1999). Hence, pathological values were defined as 
being outside this range. 
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6 Results 
 
6.1 Paper I 
A randomized controlled trial (RCT) of acupuncture treatment versus no treatment of PFPS 
was conducted with 75 participants (41 females) aged 18–45 years, with a mean of 31 years. 
All of the participants reported persistent knee pain on activity (for a mean of 6.6 years) and 
at rest (for a mean of 4.3 years). The participants were diagnosed at baseline according to 
TCM as Damp-Bi (49%), Cold-Bi (41%) or Wind-Bi (10%), with none of them diagnosed as 
Heat-Bi. The randomized group comprising 36 patients received acupuncture treatment 
according to TCM eight times over a period of 4 weeks. The control group received no 
treatment, but were allowed to follow other previously recommended treatments, such as 
medication with analgesics or NSAIDs, physiotherapy or adjustment of activity level.  
The demographic, diagnostic and clinical data did not differ between the groups at baseline. 
The pain level after performing physical tests was significantly lower in the acupuncture 
group at 5 months after inclusion (VAS = 17.9 mm) than at baseline (VAS = 27.8 mm, p=0.02) 
or in the controls (VAS = 33.5 mm, p=0.007). Participants were followed for 1 year with the 
CRS as the main outcome measure. At 12 months the mean CRS score was significantly 
higher in the acupuncture group (75.2) than in the no-treatment group (61.7, p=0.005). Pain 
and limitation of function are the main complaints in PFPS. The NNT on the defined CRS 
subscales (see Section 5.1) at the 12-month follow-up was 3.2 for pain and 3.7 for function.  
We therefore rejected our null hypothesis, concluding that acupuncture can be a beneficial 
treatment modality in reducing pain and improving function in patients with PFPS. 
 
6.2 Paper II 
In addition to knee pain and function, the levels of self-perceived health and mental distress 
were compared between PFPS patients and healthy subjects in this cross-sectional study. 
The relationships of knee pain and function with these psychological variables were 
assessed. Two independent samples consisted of one group of 25 men and women aged 18–
40 years with unilateral PFPS, and a control group (n=23) comprising healthy subjects with 
no recent history of knee pain. The CRS and triple jump test were used to assess knee 
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function. The intensity of knee pain was measured using a VAS. Self-perceived health and 
mental distress were assessed with COOP-Wonca charts and the HSCL-25 questionnaires.  
In the PFPS group, the score for pain intensity on the VAS was 24(±20.1) mm on the test day 
and had varied from 15(±11.4) to 55(±26.7) mm during the previous week. The score on the 
CRS was 57.6(±15.5) in the PFPS group. The scores for the COOP-Wonca charts were 
2.02(±0.73) in the PFPS group and 1.20(±0.53) in the controls (p≤0.001); the HSCL-25 scores 
were 1.46(±0.47) and 1.08(±0.18), respectively (p≤0.001). Correlation analysis revealed that 
CRS and VAS scores were significantly correlated with those for the COOP-Wonca charts and 
HSCL-25. 
We concluded that the level of mental distress was higher while the level of self-perceived 
health was lower in the PFPS group than in a comparable sample of healthy subjects. Our 
data also indicated that the intensity of knee pain and degree of knee function were related 
to mental distress and self-perceived health in PFPS subjects.  
 
6.3 Paper III 
This cross-sectional case–control study attempted to assess whether patients suffering from 
unilateral PFPS demonstrate dysfunction of nociceptive nerve fibres with their central 
connections by means of QST. A total of 48 subjects participated in the study. One group 
consisted of 25 men and women aged 18–40 years with unilateral PFPS, and the other group 
consisted of a comparable group of healthy subjects with no recent history of knee pain. A 
thermotesting apparatus (Thermotest, Somedic, Hoerby, Sweden) was used to assess 
thermal perception thresholds, and thresholds of heat and cold discomfort. Von Frey 
filaments were used to determine tactile sensitivity. The intensity and quality of knee pain 
were also assessed. Symptoms and signs from orthopaedic and bedside neurological 
examinations were recorded. The main outcome measures were the results of the 
thermotesting.  
Compared to the healthy controls, the mean perception threshold for “warm” was about 2  
C higher (p 0.005) in the painful knee and 1.4 C higher (p 0.01) in the non-painful knee in 
the PFPS group. The perception threshold for “cold” was 1.6 C lower (p 0.01) in the painful 
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knee of the PFPS group than in the control group. Reduced sensitivity to tactile stimulation 
was demonstrated both in the local pain area and contralaterally (p 0.001).  
This study demonstrated reduced sensibility in the local pain and homologous contralateral 
area. This indicates that pain in PFPS may have a pathophysiological aspect.  
 
6.4 Paper IV 
Study 4 aimed to assess if a subgroup of patients with PFPS have neuropathic pain related to 
the painful knee by characterizing the somatosensory phenotype and analysing the sensory 
and clinical patterns related to the knees. A total of 91 subjects aged 18–40 years with 
unilateral PFPS, and a comparable group of 23 healthy subjects aged 18–44 years were 
included in this study with a case–control design. The degree of knee function and intensity 
and quality of knee pain were assessed. Somatosensory assessments were carried out by 
bedside neurological tests and QST, assessing thermal, tactile and vibration thresholds.  
Bedside examinations detected altered sensitivity in the painful area in 48% of the PFPS 
subjects, and 32% experienced pain qualities associated with neuropathic pain (i.e. burning, 
shooting pain, painful cold, electric shocks). Median knee pain on VAS was 20 mm on the 
test day with a median highest pain intensity of 41 mm during the previous week. The CRS 
gave a mean score of 66 (±13.5) and the step down test gave a significant lower mean step 
rate compared to the non-painful extremity (p<0.001). Compared to the healthy controls, 
the median perception threshold for “warm” was 1  C higher (p 0.01) in the painful knee 
and 0.7 C higher (p 0.01) in the non-painful knee in the PFPS group. The different detection 
threshold for “warm” between the painful and non-painful contralateral knee was significant 
(p 0.01). The perception threshold for “cold” was 0.6 C higher (p 0.01) in the painful knee 
of the PFPS group than in the control group. We calculated the upper cut-off value of normal 
values of warm detection threshold to be 9.0 C. Seven subject (8%) had pathological warm 
detection threshold values according to this definition. Reduced sensitivity to tactile 
stimulation was demonstrated both in the local pain area and contralaterally with median 
scores of 6.8 g/mm² versus 4.5 g/mm² (p<0.001) in the PFPS group and 2.0 g/mm² (p<0.001) 
in the healthy controls. The vibration threshold was significantly increased in the painful 
knee compared to the contralateral non-painful knee (p=0.003).  
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We found considerable heterogeneity and overlap regarding the degree and type of 
functional abnormalities of the nervous system. However, no clear subgroup of PFPS 
subjects with neuropathic pain was identified according to the latest recommendations for 
diagnosing neuropathic pain. 
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7 General discussion 
This section discusses the results from each study separately, followed by methodological 
limitations and finally some general reflections concerning the results. 
 
7.1 Paper I 
Study 1 evaluated the effect of acupuncture treatment in addition to recommendations 
normally given to PFPS patients by health practitioners. The trial had no placebo control 
which means that it could not measure the effect of acupuncture per se. The design was 
pragmatic, being close to the clinical setting. The acupuncture stimulation was decided 
according to TCM differentiation. Our differentiation of TCM syndromes related to PFPS (i.e. 
Bi syndrome, kidney deficiency, Qi and/ or blood stagnation) is consistent with descriptions 
in available TCM textbooks and research on knee complaints (International Acupuncture 
Training Centre 1988;Brinkhaus et al. 2007).  
Concerns have been raised about using RCTs as a gold standard for assessing the outcome in 
complex non-pharmaceutical interventions such as physiotherapy and acupuncture 
(Paterson and Dieppe 2005). Important factors in these therapies are focused attention, a 
continuing assessment process, empathy, credibility of the intervention, patient expectation 
and therapeutic setting. Such factors are regarded as incidental in randomized controlled 
drug trials, whereas in non-pharmaceutical interventions they might be essential to a 
beneficial outcome. In sham-controlled acupuncture trials, the supposition is that the 
needling alone constitutes the treatment. However, if these other components significantly 
affect the treatment outcome, the sham design is inappropriate since it delivers them to 
both groups. As a consequence, the difference in treatment outcome might be greatly 
underestimated and lead to false-negative results. Therefore, the sham acupuncture design 
can only be used to compare two acupuncture interventions; that is, comparing two 
different needling techniques.  
The reduction in pain and improvement in function were larger in the group treated with 
acupuncture 12 months after inclusion. McConnell (1986) reports that a treatment-induced 
improvement in symptoms from PFPS is only temporary in many cases, since many 
investigators have found that only 30% of patients remained symptom-free at 12-month 
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follow-ups. If non-specific or psychological factors significantly affect the effectiveness of 
acupuncture, the initial effect might be expected to wear off. However, we observed a 
gradually increasing improvement in the treatment group over the 12-month follow-up, 
indicating a real treatment effect. A similar effect of acupuncture stimulation on PFPS 
subjects was subsequently confirmed by Naslund et al. (2002). The mean treatment efficacy 
in favour of the acupuncture group measured 12 months after inclusion, as expressed by the 
NNT, was 3.2 (95%CI = 2.1–6.9) for “no pain” or “occasional pain with strenuous sports”. This 
is a favourable result compared to other studies. It has not been confirmed that exercise 
reduces pain in PFPS (Heintjes et al. 2003). The effect of NSAIDS on PFPS is uncertain 
(Heintjes et al. 2004), and the NNT for tricyclic antidepressants – which is the recommended 
treatment across various neuropathic pain conditions – to achieve a 50% reduction in pain 
has ranged from 2.1 (95%CI = 1.8–2.6) to 3.1 (95%CI = 2.2–5.5) (Finnerup et al. 2007). Clinical 
trials regarding the use of acupuncture for chronic knee pain have produced conflicting 
results. Positive trials have been criticized for inadequate blinding or placebo control, and 
negative trials have been criticized because the interventions were not administered by a 
properly trained practitioner or because control interventions might have had an effect on 
the outcome measures. Still, recent systematic reviews of high-quality RCTs suggest that 
acupuncture can reduce pain and disability in patients with chronic knee pain of various 
origins (White et al. 2007;Selfe and Taylor 2008;Jubb et al. 2008). Recent RCTs have 
confirmed the beneficial effects of acupuncture on knee pain from osteoarthritis (Berman et 
al. 2004;Kukuk et al. 2005;Jubb et al. 2008). The effects of NSAIDs on arthritic knee pain 
might be no better than those of acupuncture (Bjordal et al. 2007a;Bjordal et al. 2007b). 
When considering cost-effectiveness and potential negative side effects of NSAIDs, the use 
of physical modalities such as acupuncture should be recommended in the treatment of 
musculoskeletal pain (Wonderling et al. 2004). Acupuncture is a highly demanded treatment 
option for patients with chronic musculoskeletal pain conditions, and the treatment results 
generally indicate that acupuncture is both safe and beneficial (White et al. 2001b;Yamashita 
et al. 2006;Staud 2007;Weidenhammer et al. 2007;Bucker et al. 2008). 
The knowledge of being treated can be a powerful placebo. Therefore, was the effect 
observed in this study mainly a placebo effect? Both acupuncture and sham acupuncture 
stimulate the patient’s expectation and belief regarding a potentially beneficial treatment 
and modulate activity in the reward system of the central nervous system (CNS) (Lundeberg 
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et al. 2007). The observed variations in the responses to acupuncture stimulation might also 
be genetically based (Chae et al. 2006), or due to diverse treatment doses (Vas and White 
2007;White et al. 2008). Acupuncture stimulation appears to reduce pain by influencing 
opioidergic and/or monoaminergic neurotransmission involving the brainstem, thalamus and 
pituitary (Carlsson 2002). There is also strong evidence of a therapeutic effect mediated 
through the limbic-paralimbic network (Napadow et al. 2007;Fang et al. 2008). In particular, 
the amygdala, thalamus and brainstem are key regions that moderate the conscious 
affective experience of pain (Casey et al. 1994;Craig et al. 1996;Becerra et al. 1999;Borsook 
et al. 2007). In strong needle stimulation, stress-induced analgesia and DNIC can produce 
short-term analgesic effects (Murase and Kawakita 2000;Carlsson 2002;Dhond et al. 2007). 
These mechanisms might influence the well-known clinically observed analgesic effects of 
acupuncture (Lundeberg 2006).  
Knee pain itself might influence the results, since it has been shown to influence the normal 
function of the quadriceps (Stokes and Young 1984a;Arvidsson et al. 1986). Leroux et al. 
(1995) found that pain thresholds and nociceptive flexion response thresholds were 
significantly lower in patients with PFPS. Thomee et al. (1995) found significantly reduced 
extensor strength in the most painful knee and that the strength of the quadriceps were 
significantly lower in patients with PFPS than in normal controls. The reduction in pain due 
to acupuncture treatment might modulate a nociceptive flexion reflex, and normalize a 
disturbed recruitment pattern of the quadriceps, hence improving knee biomechanics. We 
found that acupuncture improved the overall activity level 12 months after inclusion, with a 
NNT of 3.7 (95%CI = 2.2–12.7) for “no functional limitations” or “some limitations to heavy 
labour”. Pain reduction by acupuncture stimulation might also inspire patients to increase 
their general level of physical activity, and hence the initial treatment effect might be 
enhanced by increased physical activity, which would improve the long-term results.  
We found only minor side effects of acupuncture, with minor bleeding at the needling sites 
and slight tiredness. There is substantial evidence from several large surveys that 
acupuncture is a relatively safe treatment (Yamashita et al. 2000;White et al. 
2001b;Melchart et al. 2004). 
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7.2 Paper II 
The results of this Study suggest that PFPS patients can suffer from mental distress and 
reduced self-perceived health status, in addition to knee pain. Our sample of PFPS patients 
exhibited poor scores on the COOP-Wonca charts for physical fitness and daily activities, and 
according to the scores of the HSCL-25, as many as one –third of them might need 
psychological counselling (Derogatis et al. 1974). According to the results from Norway’s 
Health Statistics Database less than 10% of those aged 25―44 years scored above the cut-
off of 1.75 on the HSCL-25 (Norhealth 2005). Further, there appears to be an association 
between mental status and the intensity of knee pain and degree of knee function, since 
more pain and disability were found in subjects who expressed mental distress. Previous 
observations confirm that individuals with PFPS suffer more than healthy subjects from 
depression, anxiety and somatization (Carlsson et al. 1993;Witonski 1999;Witvrouw et al. 
2000;Thomee et al. 2002). These psychological issues are not always evident to the patients 
themselves or to the therapist, and they can vary. We found no other studies that have 
addressed the relationship of knee function and pain to mental distress and self-perceived 
health in PFPS patients. However, similar results were produced by a study on rheumatoid 
arthritis patients, where the correlation coefficient was 0.46 both between the pain index 
and anxiety, and the pain index and depression (Smedstad et al. 1995). That study supported 
the hypothesis that mental distress is secondary to pain rather than vice versa. On the other 
hand, it is widely appreciated that the psychological state of a patient can modify the 
perception of pain, and possibly even exacerbate it (Witvrouw et al. 2000). Assessing mental 
factors is therefore warranted in addition to physical tests when treating PFPS patients. We 
recommend using the COOP-Wonca charts in both clinical practice and research. 
There is increasing evidence that chronic pain affects not only the sensory perception of 
nociception but also the cognitive and affective dimensions of pain. Improved pain 
tolerability in gonarthrosis patients after acupuncture stimulation has been explained by an 
improved ability to cope with cognitive and emotional aspects of pain (Kukuk et al. 2005). 
Acupuncture stimulation is known to modulates brain activity (Dhond et al. 2008), with the 
limbic system being an important structure in processing pain and emotional responses 
(Hamann and Canli 2004). By moderating the activity of the limbic system, acupuncture 
stimulation could influence the emotional state (Campbell 1999;Wang et al. 2007;Lundeberg 
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et al. 2007;Napadow et al. 2007;Dhond et al. 2008;Fang et al. 2008). Several clinical trials 
have concluded that acupuncture is an effective therapy for depressive disorders (Luo et al. 
1998;Han et al. 2002;Han et al. 2004). This is supported by an animal model indicating a 
clear antidepressant effect of acupuncture (Dos, Jr. et al. 2008). However, a recent review of 
RCTs concluded that the available evidence is insufficient to claim that acupuncture is an 
effective treatment for depression (Mukaino et al. 2005).  
We hypothesize that dysfunctions of the neuromusculoskeletal system and long-term pain, 
as in PFPS patients, can influence brain functions so as to promote mental distress, which in 
turn reduces the pain tolerance level. The therapeutic effect of acupuncture stimulation in 
PFPS patients might be achieved, at least partially, by modulating the activity of the limbic-
paralimbic-neocortical network.  
 
7.3 Paper III 
QST of both the thermal and tactile thresholds is regarded as a sensitive but not specific 
method of testing afferent sensory pathways. Both QST and the clinical neurological 
examinations used in Study 3 indicate that the thresholds of C and Aδ sensory channels were 
significantly higher in both the painful and contralateral pain-free knees of the PFPS patients 
than in the healthy controls. This indicates that dysfunction of the CNS might cause 
pathophysiological pain in PFPS subjects (Voerman et al. 2000). A gradually developing 
contralateral pain and signs of spinal sensory modulations following unilateral peripheral 
nerve injury and after repeated injections of acid saline has been demonstrated in animal 
models (Sluka et al. 2001;Arguis et al. 2008). Injury to the L5 nerve in rats has been shown to 
increase contralateral sensitivity (mechanical allodynia) and also induce 
immunohistochemical changes in the dorsal root ganglion and structural changes in the 
contralateral dorsal horn associated with neuropathic pain conditions (Hatashita et al. 2008). 
Increased levels of glutamate in the dorsal horn has been found, and activation of acid-
sensing ion channels type 3 (ASIC3) in DRG innervating muscles has been proposed for 
initiating bilateral mechanical hyperalgesia after local muscle injury. (Skyba et al. 2002;Sluka 
et al. 2003;Skyba et al. 2005). Referred contralateral pain in animals and humans has been 
described as “mirror pain” (Aloisi et al. 1993;Maleki et al. 2000). We believe that initial 
unilateral knee pain can lead to the development of bilateral PFPS via central modulation of 
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the nervous system. Bilateral complaints have been reported in at least two-thirds of PFPS 
patients (Goldberg 1991;Vahasarja 1995;Naslund et al. 2002;Naslund et al. 2005). It is 
noteworthy that the results of thermotesting at a pain-free area (hands) differed little, if at 
all, between our PFPS and control groups. The paradoxical combination of sensory loss 
within the painful area and the pain evoked by non-noxious stimuli from mechanoreceptors 
in tissue close to or in the painful area is a characteristic feature of neuropathic pain 
(Rowbotham and Fields 1996). This can be seen in trigeminal neuralgia and post-herpetic 
neuralgia following acute herpes zoster. In PFPS patients, non-noxious tension or stress on 
tissue of the anterior knee area can induce pain with qualities similar to neuropathic pain. 
Galanty et al. (1994) reported 94% sensitivity to pain in PFPS subjects from activities such as 
squatting, prolonged sitting, and ascending or descending stairs. The present study endorses 
the value of QST in assessing somatosensory function in patients with PFPS, with the results 
indicating that patients suffering from PFPS can suffer from pathophysiological pain 
expressed as possible neuropathic pain from the knee area. Since initial unilateral knee pain 
can progress to bilateral knee pain (i.e. “mirror pain”), we recommend not using the 
contralateral knee as the only control in experimental studies. 
 
7.4 Paper IV 
By following recommendations of neuropathic pain assessments, Study 4 attempted to 
identify a subgroup of PFPS subjects with neuropathic pain (Cruccu et al. 2004;Hansson and 
Haanpaa 2007;Treede et al. 2007). Although we found ample signs of sensory dysfunctions 
related to the painful area, no clear subgroup of patients with neuropathic pain was 
identified. This lack of association between data from bedside examinations and QST was 
also shown in a group of patients with painful partial nerve injury (Leffler and Hansson 
2008). Possible explanations for the heterogeneity of the findings include patients being 
assessed at different stages in a pathological process and the same aetiology initiating 
different mechanisms. Because there is no consensus on the definition, classification, 
assessment or management of PFPS (Arroll et al. 1997;Wilk et al. 1998;Blond and Hansen 
1998;Bizzini et al. 2003;Naslund et al. 2006;MacIntyre et al. 2006), it is reasonable to suspect 
that different aetiologies underlie differences in the pain and disability experienced by PFPS 
patients, rather than this being due to different stages of the pathological development. This 
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heterogeneity of pathology makes a mechanism-based classification of PFPS patients 
difficult both clinically and in research.  
We hypothesize that the pain experienced by PFPS patients with a clearly dysfunctional 
sensory system is partly explained by a central anatomical and/ or functional reorganization. 
This might be a consequence of peripheral nerve fibre degeneration or deafferentation. 
There is evidence from animal models that neurons in lamina II (substantia gelatinosa) of the 
spinal cord dorsal horn normally receive direct input from small-diameter (C and Aδ) fibres 
and respond best to noxious stimulation (Wall et al. 1979;Hylden et al. 1986). Peripheral 
nerve damage can result in substantial degeneration of C-fibre primary afferent terminals in 
lamina II (Janig and McLachlan 1984;Lisney 1989). The loss of synaptic contacts that are 
normally present between C-fibre afferents and pain-signalling neurons in lamina II (Castro-
Lopes et al. 1990) results in the central terminals of Aβ mechanoreceptive afferents that 
normally terminate in deeper laminae (III and IV) growing into lamina II and directly 
contacting the synaptic cells (Woolf et al. 1992;Shortland and Woolf 1993). This sprouting of 
Aβ terminals depends critically on the extent of C-fibre degeneration (Woolf et al. 1992). 
After such reorganization, large-diameter primary Aβ afferents – including those that 
respond best to innocuous mechanical stimuli – provide a major direct input to spinal 
neurons that normally receive input exclusively from unmyelinated primary afferents. Thus, 
such reorganization has been suggested as a neural mechanism for the pathophysiological 
pain observed in some patients who have loss of C-fibre function, rather than C-fibre 
sensitization (Attal and Bouhassira 1999). Sprouting of thick myelinated afferents (A fibres) 
from laminae III and IV of the spinal cord is a well-established hypothesis for the structural 
basis of neuropathic pain. However, much of the evidence for the sprouting of myelinated 
fibres stems from the bulk transport of the β-cholera-toxin–horseradish-peroxidase 
conjugate, a technique that has recently been shown to be unreliable (Santha and Jancso 
2003;Shehab et al. 2003). In fact, Bao et al. (2002) showed that sprouting from deeper to 
superficial layers is much less pronounced than previously assumed. Although they claimed 
that such sprouting is only marginal, it cannot be ruled out that this still represents a 
functional circuit involved in generating pathophysiological pain. A recent study found that 
mechanical and polymodal myelinated nociceptive afferents – rather than low-threshold 
mechanoreceptive cutaneous afferents – give rise to recurving collaterals in the dorsal horn 
48 
(Woodbury et al. 2008). These collaterals project into the superficial pain-specific laminae (I 
and II) after peripheral nerve injury. This newly identified group of myelinated nociceptive 
fibres might well account for the described sprouting of mechanoreceptive afferents. It is 
suggested that these myelinated nociceptors cause pain by establishing a spinal pain 
network after nerve injury (Woodbury et al. 2008).  
We found increased thresholds of Aβ pathways in many of PFPS subjects. Also, a loss of 
input from mechanoreceptive fibres might diminish the inhibition of the projecting neurons 
and thus give rise to a “low-input” pain (Loeser 1983). Consistent with the disinhibition 
theory, thermal sensory deficits in the painful area are almost always found in patients 
suffering from centrally caused pathophysiological pain (Vestergaard et al. 1995;Bowsher 
1996;Bowsher et al. 1998). Further, it is suggested that sensory dysfunctions can induce pain 
due to imbalance of afferent activity in the dorsal column versus spinothalamic pathways 
(Beric et al. 1988;Beric 1993).  
Our findings indicate that PFPS subjects experienced deafferentation of sensory pathways 
from the region of the painful knee and also, to a smaller degree, from that of the 
contralateral non-painful knee. In addition to histological changes with anatomical and/or 
functional reorganization in the dorsal horn, other functional changes in the CNS might occur 
to induce pathophysiological pain. Such pain caused by altered function of the nervous 
system was previously defined as neuropathic pain by the IASP. According to the revised 
definition proposed by Treede et al. (2007), a history suggestive of a relevant injury affecting 
the peripheral and/ or CNS must always be present to diagnose neuropathic pain (see 
Section 1.8, criteria 2). Biomechanical dysfunctions in the lower extremity are still 
considered by most experts to be the aetiology of PFPS. Hence, PFPS patients will not 
comply with the new diagnostic criteria to diagnose neuropathic pain until solid evidence 
that show neural damage is produced. We believe that PFPS subjects might suffer from 
secondary neuroplastic changes in the sensory system that were caused by an original nerve 
lesion or dysfunction that affected the peripheral nerve endings (Sanchis-Alfonso 2008). 
Both histological and biochemical changes found in the painful area suggest an involvement 
of the peripheral nervous system in subjects with long-term anterior knee pain (Fulkerson et 
al. 1985;Fulkerson 1989;Mori et al. 1991;Sanchis-Alfonso et al. 1998;Sanchis-Alfonso et al. 
1999;Witonski and Wagrowska-Danielewicz 1999;Sanchis-Alfonso and Rosello-Sastre 
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2000;Sanchis-Alfonso et al. 2001;Sanchis-Alfonso and Rosello-Sastre 2003;Sanchis-Alfonso et 
al. 2005). Our results indicate the presence of an additional dysfunction in the CNS. 
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7.5 Methodological limitations 
The sampling process used in the studies might have introduced bias. Since most 
participants were recruited to the studies by reacting to advertisements in the local 
newspaper we might have selected samples of subjects which differ economically, socially, 
intellectually from the target population.  
The participants in the control group of the experimental study were not given sham 
acupuncture but they were allowed to receive other non-acupuncture treatments. This 
decision was made due to ethical considerations and methodological difficulties in 
implementing a true placebo treatment procedure. It has been suggested that sham 
acupuncture involving the needling of incorrect and sites that are theoretically irrelevant to 
the aim of the treatment represents a placebo treatment. However, any needling of the 
body could induce a physiological response that imitates the real treatment effect. Hence, 
such a design does not control for a placebo effect. Since most of the subjects had received 
conventional treatment and experienced negative results, it is likely that participants in the 
control group experienced a nocebo effect, meaning that the expectations to a treatment 
effect differed between the groups. To minimize the nocebo effect, we informed 
participants before randomization that if they were assigned to the control group they 
would be offered acupuncture treatment after the completion of the study. Acupuncture 
was a novel intervention for most of the participants, which is known to be associated with a 
placebo response (Paterson and Dieppe 2005). People are more motivated to participate in 
research studies at a time when they are experiencing increased discomfort, and hence a 
“reduction to the mean” phenomenon might have influenced the effect of treatment 
(Hrobjartsson and Gotzsche 2001). The study employed a semi-standardized acupuncture 
strategy. The intervention was based on a fixed number of treatment sessions (eight) and a 
small number of acupuncture points were used. The treatment strategies and numbers of 
treatment sessions can vary considerably between acupuncture trials (Ezzo et al. 
2001;Berman et al. 2004;Brinkhaus et al. 2007). From a scientific point of view, standardized 
interventions are required to ensure the reproducibility of the results of a trial. Our semi-
pragmatic methodology was chosen since most practitioners individualize the treatment, 
believing this to produce the best results (Lao et al. 2000). We cannot rule out that the 
outcome might have been different if we had applied a different acupuncture intervention 
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strategy. Further research should include trials using different numbers of acupuncture 
points and different amounts and types of needle stimulation, and it might also be beneficial 
to use consensus-reaching by experts when defining treatment strategies. To improve 
internal validity, retesting was carried out by an independent, blinded tester, and the 
participants were blinded to the outcome measurements. The outcome measurements were 
from tests validated for knee injuries, but none of the tests had been validated specifically 
for research involving PFPS subjects, which might reduce the validity of the obtained results. 
The apparent heterogeneity regarding aetiology in PFPS patients calls for stricter criteria for 
including PFPS subjects to clinical trials, in terms of gender, age, length of discomfort, 
activity level, medical history and mental profile.  
An inherent possible weakness of most small observational studies is that the sample is too 
small to be representative of the studied population. No symptoms and signs unequivocally 
diagnose the presence of PFPS. We decided to use typical inclusion criteria that are 
commonly used by other researchers (Arroll et al. 1997;Bizzini et al. 2003). Further, all 
subjects included in our four studies had been diagnosed with PFPS prior to their inclusion. 
Most had been referred to receive physiotherapy, or to an orthopaedic department because 
of their knee complaint. Therefore, the PFPS patients were probably representative of the 
total population. The criteria used to include and exclude healthy controls might have 
produced a sample healthier than the normal population and a clustering phenomenon 
(with reduced variability between the subjects). This might have resulted in differences in 
the measurements between the groups being overestimated. 
QST is a psychophysical method widely accepted for evaluating the function of small nerve 
fibres (Gruener and Dyck 1994;Yarnitsky 1997;Dyck and O'Brien 1999;Meier et al. 2001). The 
subjective character of the data gathered through psychophysical methods reduces their 
acceptance, since the subject’s attention, concentration, motivation, reaction time and 
ability to reverse the switch quickly can influence the results. People in our climate are used 
to having cold hands and feet, which would have influenced reaching the painful cold 
thresholds. Thus, the thresholds for painful cold are the least-valid thermal thresholds 
(Leffler and Hansson 2008). A lack of reproducibility and the ability to separate pretenders 
and patients with real pathology have been questioned (Verdugo and Ochoa 1992;Shy et al. 
2003). Yarnitsky et al. (1994) reported a large variability in pretenders compared to patients 
with real pathology, whereas another study found no such difference (Freeman et al. 2003). 
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The method has been regarded to be more useful for population studies than individual 
cases (Shy et al. 2003;Hansson et al. 2007;Leffler and Hansson 2008). Based on extensive 
clinical experience, Leffler and Hansson (2008) advise not to use normative data but ≥1 C 
side-difference for thermal detection thresholds as pathological cut-off value. Left-right 
comparisons are normally used in neurological testing, but can only be used where the 
contralateral side is 100% normal. Rolke et al. (2006) advise to use normative data adjusted 
for gender, age and body sites. We compared QST thresholds to data from the same body 
area in healthy subjects and calculated the normal-range to be wider than recommended. In 
the studies constituting this project, the same operator (the candidate) performed all the 
QST in the same manner every time. Moreover, none of the tested subjects was able to 
derive an explicit benefit economically or socially from the outcome, making it less likely that 
the results were influenced by feigning. 
Bedside clinical tests are qualitative and lack an adequate control and standardized stimulus 
intensity (Hansson and Haanpaa 2007). The inherent inaccuracies in such clinical testing 
might reduce the validity of the obtained results.  
Methodological weaknesses can produce errors and reduce both the internal and the 
external validity. However, the methodologies used in the studies were generally 
appropriate to their objectives. 
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7.6 Conclusion and implications 
Various causes of pathologies underlying the signs and symptoms of PFPS have been 
proposed previously. Anatomical and biomechanical abnormalities are often considered 
principal causes of the underlying pathogenesis. However, such causes are weakly correlated 
with the reported signs and symptoms. For example, often a contralateral healthy pain-free 
knee coexists with the same type of anatomical or biomechanical abnormality in the same 
individual. There is currently no evidence supporting a specific modality of treatment for 
PFPS patients.  
No previous study has assessed the somatosensory system in PFPS patients. The results from 
our studies indicate that substantial numbers of PFPS patients have a dysfunctional sensory 
system. The dysfunctions are related to sensory pathways from the painful region, and 
appear to affect central modulatory mechanisms. Further, our results indicate sensory 
changes in the spinal dorsal horn or DRG which might cause contralateral knee-pain. It is 
outside the scope of this thesis to identify or speculate in which specific changes in the 
nervous system that can cause the observed dysfunctions. However, alterations in the CNS 
due to central sensitization, anatomical reorganisation, reduced inhibition or micoglial 
activation are known causes for pathophysiological and neuropathic pain. We believe that 
the observed sensory aberrations related to the knee area promote pain from non-noxious 
mechanical stimuli in subjects with PFPS, but this remains to be confirmed. We found no 
clear relationship of the degree or quality of pain with the degree or type of sensory 
dysfunctions. Still, we suggest that a local peripheral nerve injury induced by inflammation 
or trauma can in some subjects initially lead to alterations in the afferent processing. The 
resulting secondary maladaptive neuroplastic changes might influence the inhibitory and 
disinhibitory nociceptive mechanisms. These changes cause motor dysfunction of the 
quadriceps in addition to pathophysiological pain. 
It is well documented that acupuncture stimulation can improve pain and function in 
patients suffering from knee pain. We found that sensory stimulation by acupuncture 
normalized pain in one-third and function in one-fourth of patients with PFPS. As the optimal 
treatment dose for acupuncture stimulation is still not known, further research is needed. 
Widespread effects on the nervous system have been used as explanation for the observed 
clinical effects of acupuncture stimulation. Impulses from acupuncture stimulation ascend 
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via the same sensory pathways as pain and temperature sensations. We hypothesize that 
sensory stimulation by acupuncture improves sensory dysfunction along these pathways and 
the pain-coping ability in PFPS patients. This should be further tested in future studies. 
 
The following conclusions can be drawn from the work described in this thesis: 
 Somatosensory stimulation by acupuncture should be recommended as a treatment 
modality for patients with PFPS.  
 QST is a method that can detect altered somatosensory function in PFPS subjects. In 
future research it should only be used in subjects with pathological outcome from 
clinical neurological tests. 
 Since sensory dysfunctions from the contralateral non-painful knee might also be 
present, we recommend that results from research be compared to those in healthy 
controls. 
 We were unable to identify a subgroup of PFPS subjects with neuropathic pain 
according to present recommendations for diagnosing neuropathic pain. The second 
diagnostic criterion in this recommendation excludes all painful disorders with 
underlying unknown neurological lesion or disease to be diagnosed as neuropathic 
pain. Hence, we propose that the definition is too narrow. 
 A mechanism-based understanding of the signs and symptoms in PFPS is essential to 
providing adequate treatment. Clinical neurological testing should be applied in 
addition to orthopaedic clinical test, when assessing PFPS patients. 
 Future treatment trials should be designed to: assess somatosensory processing from 
the painful area, record changes in functions of the nervous system and correlate 
such changes with changes in clinical signs and symptoms. 
 Mental distress seems to be frequently found in PFPS patients. We recommend using 
COOP-Wonca charts in assessing this dimension in PFPS subjects. 
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